Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with an error screen.
    Difference
    20%
    Check dated 2026-09-21T19:56:28.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.6.5 to v3.6.6, reflecting a deployment/version update.
    Difference
    0.0%
    Check dated 2026-08-31T17:21:38.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces v3.6.4, indicating a minor update to the page's platform or content management. This update does not alter the study details or eligibility information presented on the page.
    Difference
    0.0%
    Check dated 2026-08-09T22:43:58.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page's revision label has been updated to v3.6.4, indicating a minor system or documentation update. No study information or visible content has changed.
    Difference
    0.0%
    Check dated 2026-07-26T13:27:08.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing v3.6.2. This indicates a minor update to the page content or its documentation without altering the core study information.
    Difference
    0.0%
    Check dated 2026-07-05T04:40:50.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer software version rather than a change to primary content.
    Difference
    0.0%
    Check dated 2026-06-27T23:34:27.000Z thumbnail image

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.